You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 3, March 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Single-Dose Kinetics Predict Steady-State Concentrations of Imipramine and Desipramine

William Z. Potter, MD, PhD; Anthony P. Zavadil III, MD; Irwin J. Kopin, MD; Frederick K. Goodwin, MD

Arch Gen Psychiatry. 1980;37(3):314-320.


Abstract

• Single-dose prediction of ultimate steady-state concentrations of tricyclic antidepressants at the outset of treatment can be a valuable therapeutic tool that has had only limited application. We demonstrate accurate steady-state predictions following both the tertiary amine, imipramine hydrochloride, and the secondary amine, desipramine hydrochloride, in a carefully monitored long-term treatment patient population. Results show that long-term treatment does not alter metabolism of either imipramine or desipramine. The relative merits of single-dose predictions using total and "abbreviated" areas under the curve and concentration at 24 hours are compared. These findings demonstrate that single-dose prediction can be used as a practical therapeutic, as well as, research tool.



Author Affiliations

From the Clinical Psychobiology Branch (Drs Potter and Goodwin) and the Laboratory of Clinical Science (Dr Kopin), National Institute of Mental Health, and the Pharmacology/Toxicology Program, National Institute of General Medical Sciences (Dr. Zavadil), Bethesda, Md.


Footnotes

Accepted for publication July 9, 1979.

Reprint requests to Clinical Psychobiology Branch, National Institute of Mental Health, 9000 Rockville Pike, Bethesda, MD 20205 (Dr Potter).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Five Antidepressant Treatments in Depressed Patients: Effects on Urinary Serotonin and 5-Hydroxyindoleacetic Acid Output
Linnoila et al.
Arch Gen Psychiatry 1984;41:688-692.
ABSTRACT  

Effects of Antidepressant Treatments on Dopamine Turnover in Depressed Patients
Linnoila et al.
Arch Gen Psychiatry 1983;40:1015-1017.
ABSTRACT  

Desipramine Plasma Concentration and Antidepressant Response
Nelson et al.
Arch Gen Psychiatry 1982;39:1419-1422.
ABSTRACT  

Alteration of Norepinephrine Metabolism With Desipramine and Zimelidine in Depressed Patients
Linnoila et al.
Arch Gen Psychiatry 1982;39:1025-1028.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.